[GRG] ‘Practical Applications of Aging Research for Drug Discovery’ in Basel

To Members and Friends of the Los Angeles Gerontology
Research Group:Basel,
Switzerland in September…  Steve Coles
At 12:59 PM 7/21/2014, you wrote:
To: “Stephen Coles, M.D.,
Date: Mon, 21 Jul 2014 19:59:23 +0000
International Symposium on
Geroprotectors: Practical Applications of Aging Research for Drug
Basel, SWITZERLAND (September 2014)
Register free now!
Dear Dr. Coles,
    I’m pleased to invite you to our

International symposium on geroprotectors: practical applications of
ageing research for drug discovery, to be held as part of

MipTec, the leading European event for drug discovery.
    This is the first conference of this kind; it will
bring the top aging experts with near-market and practical projects in
aging together with the large pharmaceutical companies and investors. The
Chairman of Novartis will give a keynote talk and

the speakers will include Charles Cantor, Nir Barzilai, Barry
Merriman, Brian Kennedy, and James Kirkland.

Registration is FREE and you will have an opportunity to meet top
aging researchers with applied scientific projects and leaders of the
pharmaceutical industry in person. Please have a look at the below press
release for more details. Of course, if you have any questions, just hit
reply and I’ll be happy to help.
Warm regards,
Henry StanleyPress Officer and VP Strategy
Biogerontology Research Foundation
  Biogerontology Research Foundation to run international symposium on
geroprotectors at MipTec, September 2014
London, UK
The Biogerontology Research Foundation (BGRF),, a UK-based charity
founded to support ageing research and address the challenges of a
rapidly ageing population, announces the International symposium on
geroprotectors: practical applications of aging research for drug
discovery, a part of MipTec 2014, Europe’s largest drug discovery
conference in Basel, Switzerland, which runs September 23-25. The BGRF
will help organize the symposium with a focus on aging biomarkers, novel
approaches to geroprotector screening and practical applications of
ageing research.
Commenting on the announcement, keynote speaker Nir Barzilai, M.D.,
Director of the Institute of Aging Research at the Albert Einstein
College of Medicine, said: “The proof of concept that the aging of cells,
organisms, animals can be delayed has been demonstrated numerous times.
Drugs that target mechanisms to delay aging are ready to be tested and
may produce a tremendous longevity dividend and increase in healthy
Brian Kennedy, President and CEO of the Buck Institute for Research on
Aging in California, agreed, saying: “We need to change medicine so that
the focus is placed on keeping people healthy rather than keeping them
sick. Recent work indicates that drugs and other interventions that
target aging have the potential to achieve this goal by preventing
multiple chronic diseases of aging simultaneously.”
Adding to this, Aubrey de Grey, Ph.D., Chief Science Officer of the SENS
Research Foundation, noted: “Aging will eventually be brought under
complete medical control, mainly by “damage repair” treatments including
regenerative medicine. However, that goal is probably still a couple of
decades away. In order to ensure that as many people as possible can
benefit from it, we must work harder to maximize the efficacy of the
stop-gap treatments that already exist, and to improve those treatments
over the coming years.”
Alex Zhavoronkov, Ph.D., Director of the BGRF, commented: “I am pleased
to have been invited by Novartis to co-organize this seminal forum for
top pharmaceutical companies and leading experts in aging research to
come together to discuss practical solutions to humanity’s greatest
challenge. Scientific breakthroughs made over the past decade brought us
closer to being able to diagnose, slow down, or even prevent some of the
deleterious effects of aging. It is time to start translating some of
these discoveries from the laboratory to clinical practice.”
The symposium is free for all MipTec 2014 attendees. More information can
be found at

http://www.agingpharma.org, and information on MipTec 2014 can be
found at

  Notes to Editors 
About the Biogerontology Research

The Biogerontology Research Foundation (Charity Commission for England
and Wales registration number 1124054) seeks to fill a gap within the
research community, whereby the current scientific understanding of the
ageing process is not yet being sufficiently exploited to produce
effective medical interventions. The BGRF will fund research which,
building on the body of knowledge about how aging happens, will develop
biotechnological interventions to remediate the molecular and cellular
deficits which accumulate with age and which underlie the ill-health of
old age.
Addressing ageing damage at this most fundamental level will provide an
important opportunity to produce the effective, lasting treatments for
the diseases and disabilities of ageing, which are required to improve
quality of life in the elderly. The BGRF seeks to use the entire scope of
modern biotechnology to attack the changes that take place in the course
of aging, and to address not just the symptoms of age-related diseases
but also the mechanisms of those diseases.

Henry Stanley
Press Officer and VP Strategyhenry@bg-rf.org.uk
+44 (0)20 8133 5518




Biogerontology Research Foundation · Apt. 2354 · Chynoweth House,
Trevissome Park · Truro, TR4 8UN · UK

L. Stephen Coles, M.D., Ph.D., Cofounder
Los Angeles Gerontology Research GroupE-mail: scoles@grg.orgE-mail:


About Johnny Adams

My full-time commitment is to slow and ultimately reverse age related functional decline to increase healthy years of life. I’ve been active in this area since the 1970s, steadily building skills and accomplishments. I have a good basic understanding of the science of aging, and have many skills that complement those of scientists so they can focus on science to advance our shared mission. Broad experience Top skills: administration, management, information technology (data and programming), communications, writing, marketing, market research and analysis, public speaking, forging ethical win-win outcomes among stakeholders (i.e. high level "selling"). Knowledge in grant writing, fundraising, finance. Like most skilled professionals, I’m best described as a guy who defines an end point, then figures out how to get there. I enjoy the conception, design, execution and successful completion of a grand plan. Executive Director Gerontology Research Group (GRG). Manages Email discussion forum, web site, meetings and oversees supercentenarian (oldest humans, 110+ years) research. CEO / Executive Director Carl I. Bourhenne Medical Research Foundation (Aging Intervention Foundation), an IRS approved 501(c)(3) nonprofit. http://www.AgingIntervention.org Early contributor to Supercentenarian Research Foundation. Co-Founder Geroscience Healthspan Forum. Active contributor to numerous initiatives to increase healthy years of life. Co-authored book on conventional, practical methods available today to slow the processes of aging – nutrition, exercise, behavior modification and motivation, stress reduction, proper supplementation, damage caused by improper programs, risk reduction and others. Fundamental understanding of, and experience in the genomics of longevity (internship analyzing and curating longevity gene papers). Biological and technical includes information technology, software development and computer programming, bioinformatics and protein informatics, online education, training programs, regulatory, clinical trials software, medical devices (CAT scanners and related), hospital electrical equipment testing program. Interpersonal skills – good communication, honest, well liked, works well in teams or alone. Real world experience collaborating in interdisciplinary teams in fast paced organizations. Uses technology to advance our shared mission. Education: MBA 1985 University of Southern California -- Deans List, Albert Quon Community Service Award (for volunteering with the American Longevity Association and helping an elderly lady every other week), George S. May Scholarship, CA State Fellowship. BA psychology, psychobiology emphasis 1983 California State University Fullerton Physiological courses as well as core courses (developmental, abnormal etc). UCLA Psychobiology 1978, one brief but fast moving and fulfilling quarter. Main interest was the electrochemical basis of consciousness. Also seminars at the NeuroPsychiatric Institute. Other: Ongoing conferences, meetings and continuing education. Aging, computer software and information technology. Some molecular biology, biotech, bio and protein informatics, computer aided drug design, clinical medical devices, electronics, HIPAA, fundraising through the Assoc. of Fundraising Professionals. Previous careers include: Marketing Increasing skill set and successes in virtually all phases, with valuable experience in locating people and companies with the greatest need and interest in a product or service, and sitting across the table with decision makers and working out agreements favorable to all. Information Technology: Management, data analysis and programming in commercial and clinical trials systems, and bioinformatics and protein informatics. As IT Director at Newport Beach, CA based technology organization Success Family of Continuing Education Companies, provided online software solutions for insurance and financial professionals in small to Fortune 500 size companies. We were successful with lean team organization (the slower moving competition was unable to create similar software systems). Medical devices: At Omnimedical in Paramount CA developed and managed quality assurance dept. and training depts. for engineers, physicians and technicians. Designed hospital equipment testing program for hospital services division. In my early 20’s I was a musician, and studied psychology and music. Interned with the intention of becoming a music therapist. These experiences helped develop valuable skills used today to advance our shared mission of creating aging solutions.
This entry was posted in Uncategorized. Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s